Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease, Pulmonary |
| Therapuetic Areas: | Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 9/21/2018 |
| Start Date: | April 2010 |
| End Date: | April 2011 |
The purpose of this research study is to explore the mechanism of action of Mucinex, an oral,
over-the-counter, FDA approved expectorant in patients with acute respiratory tract
infections.
over-the-counter, FDA approved expectorant in patients with acute respiratory tract
infections.
Inclusion Criteria:
- Symptoms of cough, thickened mucus and chest congestion
- Able to produce sputum
- Non Smoker
Exclusion Criteria:
- Pregnant
- Smokers
- Fever above 101°F
- Any chronic illness
We found this trial at
1
site
Click here to add this to my saved trials
